SCHEMBL22915211

SCHEMBL22915211

O=C1O[C@@](c2cc(Cl)cc(Cl)c2)(C(F)(F)F)Nc2ccccc21

nearest known ligand 0.42

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
TP53 P04637 1/20 0.42
ALDH1A1 P00352 3/20 0.37
CHEK1 O14757 1/20 0.35
PDK2 Q15119 7/20 0.35
LMNA P02545 2/20 0.34
POLB P06746 1/20 0.34
NPSR1 Q6W5P4 1/20 0.34
TDP1 Q9NUW8 1/20 0.34
HTT P42858 1/20 0.34
MAPT P10636 2/20 0.33
GAA P10253 1/20 0.33
STK10 O94804 1/20 0.33
SLK Q9H2G2 1/20 0.33
MEN1 O00255 1/20 0.33
MAPK1 P28482 1/20 0.33
KMT2A Q03164 1/20 0.33
TNKS2 Q9H2K2 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22915142 0.89 TP53 (0.43) TP53ALDH1A1CHEK1PDK2LMNA
SCHEMBL22915127 0.87 TP53 (0.43) TP53ALDH1A1CHEK1PDK2LMNA
SCHEMBL22915193 0.84 TP53 (0.43) TP53ALDH1A1PDK2LMNAPOLB
SCHEMBL22915160 0.84 TP53 (0.52) TP53ALDH1A1LMNAPOLBNPSR1
SCHEMBL22915137 0.84 TP53 (0.52) TP53ALDH1A1LMNAPOLBNPSR1
SCHEMBL22915150 0.80 TP53 (0.43) TP53ALDH1A1PDK2LMNAPOLB
SCHEMBL22915151 0.80 TP53 (0.52) TP53ALDH1A1CHEK1PDK2LMNA
SCHEMBL22915162 0.80 TP53 (0.49) TP53ALDH1A1CHEK1PDK2LMNA
SCHEMBL22915214 0.79 ALDH1A1 (0.50) TP53ALDH1A1PDK2LMNAPOLB
SCHEMBL22915173 0.79 TP53 (0.43) TP53ALDH1A1PDK2LMNAPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11440892-B2 Substituted dihydrobenzoxazinones, dihydroquinolones, and methods of their use and synthesis NORTHWESTERN UNIVERSITY (US) 2022-09-13 US disclosed
US-20210024473-A1 SUBSTITUTED DIHYDROBENZOXAZINONES, DIHYDROQUINOLONES, AND METHODS OF THEIR USE AND SYNTHESIS NORTHWESTERN UNIVESITY 2021-01-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210024473-A1 SUBSTITUTED DIHYDROBENZOXAZINONES, DIHYDROQUINOLONES, AND METHODS OF THEIR USE AND SYNTHESIS NQO1, DHPS, NQO2 TP53 2011/4885ALDH1A1 633/4885CHEK1 1366/4885
US-11440892-B2 Substituted dihydrobenzoxazinones, dihydroquinolones, and methods of their use and synthesis NQO1, DHPS, NQO2 TP53 2011/4885ALDH1A1 633/4885CHEK1 1366/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.